Suppr超能文献

细胞骨架干扰药物对胞外5'-核苷酸酶(一种伴刀豆球蛋白A受体)的影响。

Effects of cytoskeletal perturbant drugs on ecto 5'-nucleotidase, a concanavalin A receptor.

作者信息

Carraway K L, Doss R C, Huggins J W, Chesnut R W, Carraway C A

出版信息

J Cell Biol. 1979 Dec;83(3):529-43. doi: 10.1083/jcb.83.3.529.

Abstract

Differences in cell morphology, concanavalin A-induced receptor redistributions, and the cooperativity of the inhibition of 5'-nucleotidase (AMPase) by concanavalin A (Con A) have been investigated in ascites sublines of the 13762 rat mammary adenocarcinoma cells treated with microfilament- and microtubule-perturbing drugs. By scanning electron microscopy MAT-C1 cells exhibit a highly irregular surface, covered with microvilli extending as branched structures from the cell body. MAT-A, MAT-B, and MAT-B1 cells have a more normal appearance, with unbranched microvilli, ruffles, ridges, and blebs associated closely with the cell body. MAT-C cells have an intermediate morphology. Treatment of MAT-A, MAT-B, or MAT-B1 cells with Con A causes rapid redistribution of Con A receptors. Both cytochalasins and colchicine cause alternations in the receptor redistributions. Receptors on MAT-C1 cells are highly resistant to redistribution, even in the presence of cytoskeletal perturbant drugs. The cooperativity of the inhibition of AMPase by Con A was investigated in MAT-A and MAT-C1 cells. Untreated cells exhibit no cooperativity. If either subline is treated with colchicine, cytochalasin B or D, or dibucaine, cooperativity is observed. Lumicolchicine has no effect. Theophylline or dibutyryl cyclic AMP prevents the effects of either colchicine or cytochalasin. The concentration required for half-maximal induction of cooperativity is 0.3--0.4 microM for both colchicine and cytochalasin D, which is in the appropriate range for specific microtubule and microfilament disruptions. The effectiveness of the cytochalasins (E greater than D greater than B) is consistent with their known effects on microfilaments. No direct correlation was observed between the induction of cooperativity and drug-induced changes in Con A receptor redistribution or cell morphology. The morphology of MAT-A cells is grossly altered by cytochalasins or dibucaine and somewhat less by colchicine. MAT-C1 cells exhibit more minor alterations in morphology as a result of these drug treatments. The results of this study indicate that the inhibition of AMPase, which is a Con A receptor, is a different process from the redistribution of the bulk of the Con A receptors, possibly short range membrane interactions rather than global effects on the cell.

摘要

在经微丝和微管干扰药物处理的13762大鼠乳腺腺癌细胞腹水亚系中,研究了细胞形态、伴刀豆球蛋白A诱导的受体再分布以及伴刀豆球蛋白A(Con A)对5'-核苷酸酶(AMPase)抑制作用的协同性。通过扫描电子显微镜观察,MAT-C1细胞呈现高度不规则的表面,覆盖着从细胞体延伸出的分支状微绒毛。MAT-A、MAT-B和MAT-B1细胞外观更正常,有未分支的微绒毛、褶皱、嵴和泡,与细胞体紧密相连。MAT-C细胞形态介于两者之间。用Con A处理MAT-A、MAT-B或MAT-B1细胞会导致Con A受体快速再分布。细胞松弛素和秋水仙素都会引起受体再分布的改变。MAT-C1细胞上的受体对再分布具有高度抗性,即使在存在细胞骨架干扰药物的情况下也是如此。在MAT-A和MAT-C1细胞中研究了Con A对AMPase抑制作用的协同性。未处理的细胞没有协同性。如果用秋水仙素、细胞松弛素B或D或丁卡因处理任何一个亚系,都会观察到协同性。光秋水仙素没有作用。茶碱或二丁酰环磷腺苷可阻止秋水仙素或细胞松弛素的作用。秋水仙素和细胞松弛素D诱导协同性的半最大浓度为0.3 - 0.4 microM,这在特定微管和微丝破坏的适当范围内。细胞松弛素的有效性(E>D>B)与其对微丝的已知作用一致。在协同性诱导与药物诱导的Con A受体再分布或细胞形态变化之间未观察到直接相关性。细胞松弛素或丁卡因会使MAT-A细胞的形态发生显著改变,秋水仙素的作用稍小。由于这些药物处理,MAT-C1细胞的形态变化较小。本研究结果表明,作为Con A受体的AMPase的抑制与大部分Con A受体的再分布是不同的过程,可能是短程膜相互作用而非对细胞的整体影响。

相似文献

引用本文的文献

5
5'-Nucleotidase activity in lymphocytes.淋巴细胞中的5'-核苷酸酶活性。
Histochem J. 1981 Jul;13(4):525-34. doi: 10.1007/BF01002708.

本文引用的文献

1
Microfilaments in cellular and developmental processes.细胞与发育过程中的微丝。
Science. 1971 Jan 15;171(3967):135-43. doi: 10.1126/science.171.3967.135.
2
Hormones and breast cancer.激素与乳腺癌。
Recent Prog Horm Res. 1966;22:351-79. doi: 10.1016/b978-1-4831-9825-5.50012-9.
6
Cell surface constituents of Sarcoma 180 ascites tumor cells.肉瘤180腹水肿瘤细胞的细胞表面成分。
Biochim Biophys Acta. 1973 Dec 22;330(3):254-68. doi: 10.1016/0005-2736(73)90231-9.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验